6Klomp M, Beijk MA, Varma C, et al. 1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis)a muhicenter, randomized trial comparing genous endothelial progenitor cell captu- ring stents with drug-eluting stents [ J ]..IACC Cardiovasc Interv, 2011,4(8) :896 -904. 被引量：1
7Dudek D, Onuma Y, Ormiston JA, et al. Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbabie vascular scaffold in patients with de novo coronary artery disease:the ABSORB trim [ J ]. EuroIntervention ,2012,7 (9) : 1060 - 1061. 被引量：1
